Benzinga - by Avi Kapoor, Benzinga Staff Writer.
Shares of Mobileye Global Inc. (NASDAQ: MBLY) fell sharply during Thursday’s session after the company issued preliminary FY23 financial results and initial 2024 guidance.
For the fourth quarter, the company expects revenue of $634 million-$638 million (vs. $636.39 million) and adjusted operating income of $241 million-$247 million. The company's previous implied guidance was $623 million-$648 million in revenue.
Wolfe Research analyst Shreyas Patil downgraded Mobileye Global from Outperform to Peer Perform.
Mobileye Global shares dipped 23.5% to $30.37 on Thursday.
Here are some other stocks moving in today's mid-day session.
Gainers
- Minim, Inc. (NASDAQ: MINM) shares jumped 170.2% to $4.62.
- Omega Therapeutics, Inc. (NASDAQ: OMGA) gained 92.7% to $5.26 after Novo Nordisk entered into a research collaboration with the company.
- Avenue Therapeutics, Inc. (NASDAQ: ATXI) shares climbed 65.8% to $0.2920 after the company announced it reached a final agreement with the FDA for the Phase 3 safety study for IV tramadol.
- Jeffs' Brands Ltd(NASDAQ: JFBR) gained 40% to $4.41 after surging 25% on Wednesday. Jeffs' Brands, last month, signed non-binding letters of intent with Sky Growth Partners to invest in a DLP laser-based system for counter-drone solutions and laser-based wireless charging technology.
- Mobix Labs, Inc. (NASDAQ: MOBX) gained 33.3% to $4.00. Mobix Labs was awarded 15-month contract to supply EMI filtered connectors as part of US Army's M-1 Abrams Tank Program.
- ATIF Holdings Limited (NASDAQ: ATIF) jumped 30.6% to $1.32.
- Adicet Bio, Inc. (NASDAQ: ACET) surged 26.1% to $2.22. Adicet Bio issued corporate updates and highlighted upcoming priorities for its pipeline programs in 2024.
- Smart for Life, Inc. (NASDAQ: SMFL) gained 22.6% to $1.9999.
- XORTX Therapeutics Inc. (NASDAQ: XRTX) rose 21.7% to $2.97. Alliance Global Partners analyst James Molloy maintained XORTX Therapeutics with a Buy and raised the price target from $9 to $14.
- Kintara Therapeutics, Inc. (NASDAQ: KTRA) climbed 20.1% to $0.1690 after falling over 11% on Wednesday. Kintara Therapeutics, last month, announced a review of strategic alternatives focused on maximizing stockholder value.
- QuantumScape Corporation (NYSE: QS) gained 18.5% to $7.70.
- The Arena Group Holdings, Inc. (NYSE: AREN) shares rose 16.8% to $2.44 after falling over 9% on Wednesday. Arena Group Board, last month, terminated employment of CEO Ross Levinsohn.
- NuZee, Inc. (NASDAQ: NUZE) gained 16.7% to $2.9999.
- Keros Therapeutics, Inc. (NASDAQ: KROS) gained 15.7% to $47.72. Keros Therapeutics priced upsized $140 million public offering of 3.5 million common shares at $40 per share.
- Dyne Therapeutics, Inc. (NASDAQ: DYN) gained 14.6% to $16.92. Dyne Therapeutics announced an underwritten public offering of $175 million of common stock.
- TMC the metals company Inc. (NASDAQ: TMC) rose 13.8% to $1.32.
- MINISO Group Holding Limited (NYSE: MNSO) gained 9.7% to $21.87.
- Nikola Corporation (NASDAQ: NKLA) rose 8.4% to $0.8031. Nikola said it produced 42 and wholesaled 35 Class 8 Nikola Hydrogen Fuel Cell Vehicles for US and Canada customers in 2023.
- Select Medical Holdings Corporation (NYSE: SEM) gained 6.4% to $25.00. Select Medical announced potential separation of Concentra.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or
remove ads
.
Losers- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) shares fell 36% to $0.58 after the company announced pricing of $9.0 million public offering.
- E-Home Household Service Holdings Limited (NASDAQ: EJH) fell 33.2% to $0.9894.
- OPKO Health, Inc. (NASDAQ: OPK) shares dipped 28% to $1.0799. OPKO Health disclosed a private offering of Convertible Senior Notes due 2029.
- Hitek Global Inc. (NASDAQ: HKIT) tumbled 25.2% to $0.77.
- Relmada Therapeutics, Inc. (NASDAQ: RLMD) declined 24% to $3.44 after the company issued a corporate update.
- Nemaura Medical Inc. (NASDAQ: NMRD) dipped 21.2% to $0.1009.
- ABVC BioPharma, Inc. (NASDAQ: ABVC) shares fell 20.1% to $1.5395. ABVC BioPharma shares jumped over 60% on Wednesday after the company and its subsidiary received a milestone payment of 46 million shares from AiBtl BioPharma under a global licensing payment.
- LifeMD, Inc. (NASDAQ: LFMD) fell 20.1% to $6.20.
- Singularity Future Technology Ltd. (NASDAQ: SGLY) tumbled 18.3% to $0.47.
- cbdMD, Inc. (NYSE: YCBD) dipped 16.1% to $0.8302.
- RiskOn International, Inc. (NASDAQ: ROI) shares fell 13.7% to $0.2536 after dipping around 35% on Wednesday.
- WW International, Inc. (NASDAQ: WW) tumbled 13.6% to $6.59.
- Pinstripes Holdings Inc. (NYSE: PNST) declined 13.1% to $7.13.
- Avanos Medical, Inc. (NASDAQ: AVNS) fell 12.9% to $18.91 after reporting preliminary Q4 and FY23 financial results.
- NexImmune, Inc. (NASDAQ: NEXI) fell 11.5% to $5.49 after jumping around 153% on Wednesday.
- Schnitzer Steel Industries, Inc. (NASDAQ: RDUS) declined 9.8% to $26.61 following first-quarter results.
- Evotec SE (NASDAQ: EVO) shares declined 9.2% to $9.60. Evotec and Owkin announced an A.I.-powered integrated multi-target collaboration in oncology, immunology and inflammation.
- Walgreens Boots Alliance, Inc. (NASDAQ: WBA) dipped 8.5% to $23.39 following quarterly results.
- MultiPlan Corporation (NYSE: MPLN) fell 7.3% to $1.3150. MultiPlan named Travis Dalton as President and CEO on March 1, 2024.
- First Wave BioPharma, Inc. (NASDAQ: FWBI) shares fell 7.1% to $5.07. First Wave BioPharma shares jumped 43% on Wednesday after Roth MKM maintained a Buy rating on the stock and adjusted its target from $11 to $40.
- Altice USA, Inc. (NYSE: ATUS) fell 4.8% to $2.9310.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or
remove ads
.
Now Read This: Bitcoin Rises Above $43,000 Following ADP Data; Beam Emerges As Top Gainer
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.